Krystal Biotech, Inc.
(NASDAQ: KRYS)

Krystal Biotech, Inc. operates as a biotechnology company, which engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.

221.960

+4.500 (+2.07%)
Range 213.833 - 222.660   (4.13%)
Open 215.800
Previous Close 217.460
Bid Price 109.170
Bid Volume 14
Ask Price 118.920
Ask Volume 18
Volume 397,881
Value -
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis